Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?
Stoessl
A J
AJ
D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D003342:Corpus Striatum / Q000378:metabolism / Q000473:pathology; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D004298:Dopamine / Q000378:metabolism*; D005462:Fluorine Radioisotopes; D006801:Humans; D009434:Neural Pathways / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000175:diagnosis* / Q000378:metabolism*; D012720:Severity of Illness Index; D013378:Substantia Nigra / Q000378:metabolism / Q000473:pathology; D013747:Tetrabenazine / Q000031:analogs & derivatives*; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon
D005462:Fluorine Radioisotopes; C043437:fluorodopa F 18; C032811:dihydrotetrabenazine; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D013747:Tetrabenazine